Wirkungen der Melatonin in der Behandlung von kardiovaskulären Krankheiten: Letztes Jahr Fortschritte



Viele Studien zeigen dass die Melatonin eine wichtige Rolle in der Behandlung von kardiovaskulären Krankheiten spielen könnte. Die Untersuchungen haben bewiesen, dass die Melatonin wichtige Wirkungen bei Ischemia Beschädigungen, pulmonärer Hypertonie, Bluthochdruck, Herzklappen Krankenheiten und  Lipidostoffwechsel haben könnte. Die Melatonin kann eine neue Wahl in der Behandlung von kardiovaskulären Krankheiten sein.

Effects of melatonin on cardiovascular diseases: progress in the past year.
Curr Opin Lipidol. 2016 Apr 12;
Authors: Sun H, Gusdon AM, Qu S

Abstract
PURPOSE OF REVIEW: Melatonin is a neuroendocrine hormone synthesized primarily by the pineal gland. Numerous studies have suggested that melatonin plays an important role in various cardiovascular diseases. In this article, recent progress regarding melatonin's effects on cardiovascular diseases is reviewed.
RECENT FINDINGS: In the past year, studies have focused on the mechanism of protection of melatonin on cardiovascular diseases, including myocardial ischemia-reperfusion injury, myocardial hypoxia-reoxygenation injury, pulmonary hypertension, hypertension, atherosclerosis, valvular heart diseases, and other cardiovascular diseases.
SUMMARY: Studies have demonstrated that melatonin has significant effects on ischemia-reperfusion injury, myocardial chronic intermittent hypoxia injury, pulmonary hypertension, hypertension, valvular heart diseases, vascular diseases, and lipid metabolism. As an inexpensive and well tolerated drug, melatonin may be a new therapeutic option for cardiovascular disease.

PMID: 27075419 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/27075419?dopt=Abstract



Key Melatonin